Skip to main content
. 2016 Nov 16;38(11):552–558. doi: 10.1055/s-0036-1593986

Table 3. Reproductive outcomes of assisted reproduction cycles.

Group 1
TSH < 2.5 mIU/L
Group 2
TSH 2.5–4.0 mIU/L
Group 3
TSH 4.0–10 mIU/L
(n = 455) (n = 162) (n = 33) p
Cycles with fresh embryo transfer, n (%) 369 (81.1) 136 (84) 24 (72.7) 0.31
Cycles with fresh top quality embryo transfer, n (%) 214 (47) 75 (46.3) 14 (42.4) 0.87
Cycles with oocyte cryopreservation, n (%) 20 (4.4) 4 (2.5) 2 (6.1) 0.46
Cycles with embryo cryopreservation, n (%) 183 (40.2) 63 (38.9) 12 (36.4) 0.88
Positive pregnancy test, n (%) 133 (29.2) 52 (32.1) 9 (27.3) 0.75
Clinical pregnancy rate, n (%) 111 (24.4) 42 (25.9) 8 (24.2) 0.93
Live birth rate, n (%) 92 (20.2) 36 (22.2) 7 (21.2) 0.86
Miscarriage rate, n (%) 19 (17.1) 6 (14.3) 1 (12.5) 0.93
Multiple pregnancy rate, n (%) 30 (27) 9 (21.4) 2 (25) 0.90

Abbreviation: TSH: thyroid-stimulating hormone.

Notes: Clinical pregnancy rate: number of patients with embryos exhibiting a heartbeat on transvaginal ultrasound (TVUS) 4 to 5 weeks after embryo transfer divided by the number of cycles × 100.

Miscarriage rate: number of patients who miscarried divided by the number of patients who had clinical pregnancy × 100.

Live birth rate: number of patients who delivered a live birth divided by the number of patients who had clinical pregnancy × 100.

Multiple pregnancy rates: number of patients who delivered more than one live birth divided by the number of patients who had clinical pregnancy × 100.

p determined by Chi-squared test.